A chest belt that maps the lungs could help breathing machines fit better
NCT ID NCT07810283
First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time
Summary
Researchers at the Royal Free Hospital are testing whether electrical impedance tomography (EIT), a radiation-free imaging method that uses a chest belt and low-level electrical currents, can help clinicians adjust breathing machines for people with chronic respiratory failure. The study has two parts: one looks at whether EIT-guided changes to non-invasive ventilation settings help patients use their machines more and feel better, and the other watches how air moves in the lungs during cough assist sessions. About 20 adults with chronic respiratory failure or neuromuscular disease take part, and the team compares measurements before and after one month on the new settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- electrical impedance tomography, a radiation-free lung imaging device worn as a chest belt
- What this could lead to
- If it works, EIT could give clinicians a real-time view of the lungs to tailor breathing machine settings, which may help people tolerate their machines better and spend less time in hospital.
- What could go wrong
- This is a small feasibility study of about 20 people at one hospital, so it cannot prove that EIT-guided settings improve outcomes. The belt may not produce clear enough pictures, and any benefits seen in this setting may not hold for other patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Work package 1: * Patients diagnosed with chronic respiratory failure * Requiring domiciliary NIV and non-concordant with NIV (\<4hrs/night for 70% in the last 1month) * Age ≥18years Work package 2: * Age ≥18years * Patients diagnosed with a neuromuscular disease * Currently use or have previously used MI:E for clinical use or as part of a research study
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Work package 1: * Patients diagnosed with chronic respiratory failure * Requiring domiciliary NIV and non-concordant with NIV (\<4hrs/night for 70% in the last 1month) * Age ≥18years Work package 2: * Age ≥18years * Patients diagnosed with a neuromuscular disease * Currently use or have previously used MI:E for clinical use or as part of a research study Exclusion Criteria: * Exclusion criteria work package 1: * Unable to provide informed consent * Contraindication to EIT: * Active implantable cardiac device * Active pacemaker * Open wound over the site of the EIT belt * Chest circumference \< 80cm or \> 116cm * Psychosocial factors attributable to non-concordance * Excessive mask leak contributing to non-concordance * Mental health diagnosis contributing to non-concordance * Pregnancy Exclusion criteria work package 2: * Unable to provide informed consent * Contraindication to EIT: * Active implantable cardiac device * Active pacemaker * Open wound over the site of the EIT belt * Chest circumference \< 80cm or \> 116cm * Pregnancy * Evidence of obstructive airways disease FEV1:FVC\<0.7. * Contraindication to MI:E: * Un-drained pneumothorax. * Severe bronchospasm. * Head injury with Intercranial pressure (ICP) \>25 mm Hg. * Severe arterial hypotension (mean arterial pressure \<65 mm Hg). * Tracheoesophageal fistula. * Significant haemoptysis. * Facial fractures. * Vomiting. * Flail segment * Epistaxis within 2 weeks.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic respiratory failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Royal Free Hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can Device-Preserved donor lungs boost transplant success?
- Can electrical muscle stimulation boost exercise benefits after menopause?